WAVE Life Sciences Ltd (WVE)
6.18
+0.01
(+0.16%)
USD |
NASDAQ |
May 31, 16:00
6.175
0.00 (0.00%)
After-Hours: 20:00
WAVE Life Sciences Enterprise Value: 575.88M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 575.88M |
| May 30, 2024 | 574.66M |
| May 29, 2024 | 553.84M |
| May 28, 2024 | 570.98M |
| May 24, 2024 | 580.78M |
| May 23, 2024 | 564.86M |
| May 22, 2024 | 607.72M |
| May 21, 2024 | 593.03M |
| May 20, 2024 | 600.37M |
| May 17, 2024 | 585.68M |
| May 16, 2024 | 541.59M |
| May 15, 2024 | 541.59M |
| May 14, 2024 | 534.25M |
| May 13, 2024 | 515.88M |
| May 10, 2024 | 507.30M |
| May 09, 2024 | 524.45M |
| May 08, 2024 | 535.47M |
| May 07, 2024 | 528.12M |
| May 06, 2024 | 522.43M |
| May 03, 2024 | 570.13M |
| May 02, 2024 | 538.33M |
| May 01, 2024 | 512.64M |
| April 30, 2024 | 422.12M |
| April 29, 2024 | 412.34M |
| April 26, 2024 | 389.10M |
| Date | Value |
|---|---|
| April 25, 2024 | 398.88M |
| April 24, 2024 | 431.91M |
| April 23, 2024 | 440.47M |
| April 22, 2024 | 411.11M |
| April 19, 2024 | 414.78M |
| April 18, 2024 | 406.22M |
| April 17, 2024 | 405.00M |
| April 16, 2024 | 462.49M |
| April 15, 2024 | 521.20M |
| April 12, 2024 | 528.54M |
| April 11, 2024 | 553.01M |
| April 10, 2024 | 557.90M |
| April 09, 2024 | 530.99M |
| April 08, 2024 | 528.54M |
| April 05, 2024 | 542.00M |
| April 04, 2024 | 534.66M |
| April 03, 2024 | 545.67M |
| April 02, 2024 | 583.59M |
| April 01, 2024 | 590.93M |
| March 31, 2024 | 573.80M |
| March 28, 2024 | 554.35M |
| March 27, 2024 | 538.45M |
| March 26, 2024 | 491.78M |
| March 25, 2024 | 506.45M |
| March 22, 2024 | 505.23M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-36.38M
Minimum
May 13 2022
1.080B
Maximum
Dec 13 2019
268.33M
Average
231.84M
Median
Enterprise Value Benchmarks
| Haw Par Corp Ltd | -853.06M |
| ASLAN Pharmaceuticals Ltd | 17.82M |
| EUDA Health Holdings Ltd | -- |
| CytoMed Therapeutics Ltd | 18.45M |
| Mobile-health Network Solutions | 45.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -31.56M |
| Revenue (Quarterly) | 12.54M |
| Total Expenses (Quarterly) | 47.00M |
| EPS Diluted (Quarterly) | -0.24 |
| Profit Margin (Quarterly) | -251.7% |
| Earnings Yield | -8.41% |
| Normalized Earnings Yield | -9.592 |